PT1262186E - Composicoes de antibioticos azalido - Google Patents

Composicoes de antibioticos azalido

Info

Publication number
PT1262186E
PT1262186E PT02253796T PT02253796T PT1262186E PT 1262186 E PT1262186 E PT 1262186E PT 02253796 T PT02253796 T PT 02253796T PT 02253796 T PT02253796 T PT 02253796T PT 1262186 E PT1262186 E PT 1262186E
Authority
PT
Portugal
Prior art keywords
azalido
antibiotic compositions
compositions
antibiotic
acids
Prior art date
Application number
PT02253796T
Other languages
English (en)
Inventor
Wayne A Boettner
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PT1262186E publication Critical patent/PT1262186E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT02253796T 2001-05-31 2002-05-30 Composicoes de antibioticos azalido PT1262186E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29467701P 2001-05-31 2001-05-31

Publications (1)

Publication Number Publication Date
PT1262186E true PT1262186E (pt) 2004-06-30

Family

ID=23134451

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02253796T PT1262186E (pt) 2001-05-31 2002-05-30 Composicoes de antibioticos azalido

Country Status (12)

Country Link
US (1) US20030092640A1 (pt)
EP (1) EP1262186B1 (pt)
JP (1) JP2003040782A (pt)
AT (1) ATE264684T1 (pt)
BR (1) BR0201973A (pt)
CA (1) CA2387821A1 (pt)
DE (1) DE60200391T2 (pt)
DK (1) DK1262186T3 (pt)
ES (1) ES2218509T3 (pt)
MX (1) MXPA02005381A (pt)
PT (1) PT1262186E (pt)
TR (1) TR200400954T4 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
JP2007277095A (ja) * 2004-07-02 2007-10-25 Wakamoto Pharmaceut Co Ltd アジスロマイシン含有可逆性熱ゲル化水性組成物
WO2007112616A1 (fr) * 2006-04-04 2007-10-11 Union Plastic (Hangzhou) Machinery Co., Ltd. Procédé de commande d'une machine hydraulique pour économiser de l'énergie ou améliorer l'efficacité
EP2098219A1 (en) 2008-03-05 2009-09-09 PARI Pharma GmbH Macrolide compositions having improved taste and stability
WO2011104557A1 (en) * 2010-02-24 2011-09-01 Arecor Limited Protein formulations
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103690560B (zh) * 2013-12-17 2016-08-17 辽宁海思科制药有限公司 一种转化糖电解质注射液药物组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
ATE243703T1 (de) * 2000-01-27 2003-07-15 Pfizer Prod Inc Antibiotische azalid-zusammensetzungen
PL359861A1 (en) * 2000-04-27 2004-09-06 Pfizer Products Inc. The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals

Also Published As

Publication number Publication date
EP1262186B1 (en) 2004-04-21
BR0201973A (pt) 2003-04-22
TR200400954T4 (tr) 2004-07-21
JP2003040782A (ja) 2003-02-13
US20030092640A1 (en) 2003-05-15
DE60200391T2 (de) 2005-05-04
EP1262186A1 (en) 2002-12-04
ES2218509T3 (es) 2004-11-16
ATE264684T1 (de) 2004-05-15
MXPA02005381A (es) 2002-12-09
DK1262186T3 (da) 2004-07-26
DE60200391D1 (de) 2004-05-27
CA2387821A1 (en) 2002-11-30

Similar Documents

Publication Publication Date Title
MXPA02011900A (es) Composicion fotosensible para fabricacion de fotorresistente.
ATE243703T1 (de) Antibiotische azalid-zusammensetzungen
BR0206155B1 (pt) composiÇÕes copolimÉricas cristalinas de propileno tendo propriedades àpticas e de selagem aperfeiÇoadas e solubilidade reduzida.
CY1107896T1 (el) Παρασκευη λυοφιλιωμενης παντοπραζολης και ενεση παντοπραζολης
CY1108456T1 (el) Ενωσεις βενζιμιδαζολονης
WO2003017990A3 (en) Ophthalmic composition comprising an ascomycin
PT1262186E (pt) Composicoes de antibioticos azalido
WO2001034647A3 (en) Animal collagens and gelatins
DE60208404D1 (de) Kreuzverquerte glycopeptid-cephalosporin-antibiotika
ECSP034598A (es) Compuesto lactamico
CY1106376T1 (el) Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν
CY1105345T1 (el) Φαινυλαλκινια
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
DK1192139T3 (da) Fremstilling af quinolinsubstituerede carbonat- og carbamatderivater
ATE315380T1 (de) Epothilon zusammensetzungen
ITRM20000266A0 (it) Procedimento migliorato per la preparazione di (e,z) 3-(2-amminoetossimmino)-androstano-6, 17-dione e di suoi analoghi.
AU2002249863A1 (en) Stabilization of radiopharmaceutical compositions using hydrophilic thioether or a hydrophilic 6-hydroxy chroman
WO2003011266A3 (en) Azalide antibiotic compositions
NO20014755L (no) C(7)-karbonatsubstituerte taxaner som antitumormidler
PT1339703E (pt) Processo para a preparacao de paclitaxel
WO2000040589A3 (en) Novel derivatives from the class of oleandomycin
AU2002357931A1 (en) Gated electron field emitter having supported gate
ITMI992127A0 (it) Processo per la preparazione di un composto aril-piridinico
MXPA03009538A (es) Sulfato de compuesto de cefem.
BR0107724A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica e, uso de um composto